Blair William & Co. IL Reduces Stake in Exact Sciences Corporation

Investment firm cuts position in medical research company by 14.9% in Q3

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Blair William & Co. IL, an investment management firm, reduced its stake in Exact Sciences Corporation (NASDAQ:EXAS) by 14.9% during the third quarter of 2026. The firm now owns 139,494 shares of the medical research company's stock, valued at approximately $7.63 million.

Why it matters

Exact Sciences is a leading molecular diagnostics company known for its Cologuard colorectal cancer screening test. Changes in institutional ownership of the company's stock can provide insights into market sentiment and the stock's performance.

The details

According to a recent SEC filing, Blair William & Co. IL sold 24,493 shares of Exact Sciences during the third quarter, reducing its total position to 139,494 shares. The firm now owns approximately 0.07% of the company's outstanding stock. Exact Sciences' stock has seen significant volatility in recent quarters as the company navigates the competitive diagnostics market and works to expand adoption of its Cologuard test.

  • Blair William & Co. IL made the changes to its Exact Sciences position during the third quarter of 2026.

The players

Blair William & Co. IL

An investment management firm that owns a stake in Exact Sciences Corporation.

Exact Sciences Corporation

A molecular diagnostics company known for its Cologuard colorectal cancer screening test.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Blair William & Co. IL's Exact Sciences position reflects the ongoing challenges and competitive dynamics in the diagnostics industry. Investors will likely continue to closely monitor Exact Sciences' performance and market share as it works to drive broader adoption of its Cologuard test.